NO20012995D0 - Forbindelse nyttige for behandling av inflammatoriske sykdommer - Google Patents
Forbindelse nyttige for behandling av inflammatoriske sykdommerInfo
- Publication number
- NO20012995D0 NO20012995D0 NO20012995A NO20012995A NO20012995D0 NO 20012995 D0 NO20012995 D0 NO 20012995D0 NO 20012995 A NO20012995 A NO 20012995A NO 20012995 A NO20012995 A NO 20012995A NO 20012995 D0 NO20012995 D0 NO 20012995D0
- Authority
- NO
- Norway
- Prior art keywords
- inflammatory diseases
- compound useful
- treating inflammatory
- treating
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828074.6A GB9828074D0 (en) | 1998-12-18 | 1998-12-18 | Therapeutically useful compounds |
| PCT/EP1999/010000 WO2000037444A1 (en) | 1998-12-18 | 1999-12-16 | Compounds useful in the treatment of inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012995D0 true NO20012995D0 (no) | 2001-06-15 |
| NO20012995L NO20012995L (no) | 2001-08-15 |
Family
ID=10844608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012995A NO20012995L (no) | 1998-12-18 | 2001-06-15 | Forbindelser nyttige for behandling av inflammatoriske sykdommer |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6867192B1 (no) |
| EP (1) | EP1140837B1 (no) |
| JP (1) | JP4431282B2 (no) |
| KR (1) | KR20010101258A (no) |
| CN (1) | CN1330637A (no) |
| AR (1) | AR023727A1 (no) |
| AT (1) | ATE273954T1 (no) |
| AU (1) | AU760169B2 (no) |
| BR (1) | BR9916282A (no) |
| CA (1) | CA2355630A1 (no) |
| CO (1) | CO5170533A1 (no) |
| CZ (1) | CZ20012209A3 (no) |
| DE (1) | DE69919580T2 (no) |
| ES (1) | ES2226488T3 (no) |
| GB (1) | GB9828074D0 (no) |
| GT (1) | GT199900217A (no) |
| HK (1) | HK1038744A1 (no) |
| HU (1) | HUP0104867A3 (no) |
| IL (1) | IL142908A0 (no) |
| NO (1) | NO20012995L (no) |
| NZ (1) | NZ511478A (no) |
| PE (1) | PE20001387A1 (no) |
| PL (1) | PL348059A1 (no) |
| TR (1) | TR200101709T2 (no) |
| WO (1) | WO2000037444A1 (no) |
| ZA (1) | ZA200103948B (no) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003519697A (ja) | 1999-12-28 | 2003-06-24 | ファイザー・プロダクツ・インク | 炎症性疾患、自己免疫疾患および呼吸器疾患の処置に有用な非ペプチド系のｖｌａ−４依存性細胞結合阻害薬 |
| GB0014869D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014883D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014947D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014849D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
| GB0014892D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014851D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014881D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
| GB0127423D0 (en) * | 2001-11-15 | 2002-01-09 | Glaxo Group Ltd | Process |
| GB0218630D0 (en) | 2002-08-10 | 2002-09-18 | Tanabe Seiyaku Co | Novel compounds |
| JP2006528988A (ja) | 2003-05-20 | 2006-12-28 | ジェネンテック・インコーポレーテッド | アルファ−４インテグリンのチオカルバメート阻害剤 |
| CN102512675A (zh) | 2004-06-04 | 2012-06-27 | 健泰科生物技术公司 | 用于治疗多发性硬化的方法 |
| US9082353B2 (en) | 2010-01-05 | 2015-07-14 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US8482496B2 (en) | 2006-01-06 | 2013-07-09 | Pixtronix, Inc. | Circuits for controlling MEMS display apparatus on a transparent substrate |
| US9261694B2 (en) | 2005-02-23 | 2016-02-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
| US8519945B2 (en) | 2006-01-06 | 2013-08-27 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US7999994B2 (en) | 2005-02-23 | 2011-08-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
| US7742016B2 (en) | 2005-02-23 | 2010-06-22 | Pixtronix, Incorporated | Display methods and apparatus |
| US8310442B2 (en) | 2005-02-23 | 2012-11-13 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US8159428B2 (en) | 2005-02-23 | 2012-04-17 | Pixtronix, Inc. | Display methods and apparatus |
| US9158106B2 (en) | 2005-02-23 | 2015-10-13 | Pixtronix, Inc. | Display methods and apparatus |
| US9229222B2 (en) | 2005-02-23 | 2016-01-05 | Pixtronix, Inc. | Alignment methods in fluid-filled MEMS displays |
| US20070205969A1 (en) | 2005-02-23 | 2007-09-06 | Pixtronix, Incorporated | Direct-view MEMS display devices and methods for generating images thereon |
| MY149159A (en) | 2005-11-15 | 2013-07-31 | Hoffmann La Roche | Method for treating joint damage |
| US8526096B2 (en) | 2006-02-23 | 2013-09-03 | Pixtronix, Inc. | Mechanical light modulators with stressed beams |
| US9176318B2 (en) * | 2007-05-18 | 2015-11-03 | Pixtronix, Inc. | Methods for manufacturing fluid-filled MEMS displays |
| TW201014605A (en) | 2008-09-16 | 2010-04-16 | Genentech Inc | Methods for treating progressive multiple sclerosis |
| US8169679B2 (en) | 2008-10-27 | 2012-05-01 | Pixtronix, Inc. | MEMS anchors |
| WO2010075249A2 (en) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | A method for treating rheumatoid arthritis with b-cell antagonists |
| CN102834763B (zh) | 2010-02-02 | 2015-07-22 | 皮克斯特罗尼克斯公司 | 用于制造填充冷密封流体的显示装置的方法 |
| CN103000141B (zh) | 2010-02-02 | 2016-01-13 | 皮克斯特罗尼克斯公司 | 用于控制显示装置的电路 |
| WO2013101771A2 (en) | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| EP2809684A1 (en) | 2012-01-31 | 2014-12-10 | Genentech, Inc. | Anti-ig-e m1' antibodies and methods using same |
| US9134552B2 (en) | 2013-03-13 | 2015-09-15 | Pixtronix, Inc. | Display apparatus with narrow gap electrostatic actuators |
| WO2015181837A2 (en) * | 2014-05-30 | 2015-12-03 | Sphaera Pharma Pvt. Ltd. | Novel compounds as anti-tubercular agents |
| EP3319639B1 (en) * | 2015-07-08 | 2020-11-18 | Axerovision, Inc. | Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions |
| WO2017062682A2 (en) | 2015-10-06 | 2017-04-13 | Genentech, Inc. | Method for treating multiple sclerosis |
| CA3026074A1 (en) * | 2016-06-01 | 2017-12-07 | M3 Biotechnology, Inc. | N-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide compounds and their use to treat neurodegenerative diseases |
| CN109722455B (zh) * | 2017-10-31 | 2022-03-11 | 中国科学院天津工业生物技术研究所 | 微生物发酵生产谷内酯的方法、工程菌及应用 |
| EP3810085A1 (en) | 2018-06-20 | 2021-04-28 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| CA3115830C (en) | 2018-10-30 | 2023-09-12 | Gilead Sciences, Inc. | Compounds for inhibition of .alpha.4.beta.7 integrin |
| US11224600B2 (en) | 2018-10-30 | 2022-01-18 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
| JP7214882B2 (ja) | 2018-10-30 | 2023-01-30 | ギリアード サイエンシーズ， インコーポレイテッド | アルファ４ベータ７インテグリン阻害剤としてのイミダゾピリジン誘導体 |
| AU2019373240B2 (en) | 2018-10-30 | 2023-04-20 | Gilead Sciences, Inc. | Quinoline derivatives as alpha4beta7 integrin inhibitors |
| US11578069B2 (en) | 2019-08-14 | 2023-02-14 | Gilead Sciences, Inc. | Compounds for inhibition of α4 β7 integrin |
| KR20230110514A (ko) * | 2020-10-21 | 2023-07-24 | 아주라 오프탈믹스 엘티디 | 안구 장애의 치료를 위한 화합물 및 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1593858A1 (de) | 1967-03-02 | 1970-10-29 | Hoechst Ag | Verfahren zur Herstellung tyrosinhaltiger Peptide und deren Derivaten |
| US4105602A (en) * | 1975-02-10 | 1978-08-08 | Armour Pharmaceutical Company | Synthesis of peptides with parathyroid hormone activity |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| CA2291778A1 (en) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| JP2002501537A (ja) * | 1997-05-29 | 2002-01-15 | メルク エンド カンパニー インコーポレーテッド | 細胞接着阻害薬としてのスルホンアミド類 |
| DE69833654T2 (de) | 1997-05-29 | 2006-12-14 | Merck & Co., Inc. (A New Jersey Corp.) | Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren |
| US6093696A (en) | 1997-05-30 | 2000-07-25 | Celltech Therapeutics, Limited | Tyrosine derivatives |
-
1998
- 1998-12-18 GB GBGB9828074.6A patent/GB9828074D0/en not_active Ceased
-
1999
- 1999-12-15 AR ARP990106429A patent/AR023727A1/es not_active Application Discontinuation
- 1999-12-15 CO CO99078241A patent/CO5170533A1/es not_active Application Discontinuation
- 1999-12-16 NZ NZ511478A patent/NZ511478A/en unknown
- 1999-12-16 PL PL99348059A patent/PL348059A1/xx not_active Application Discontinuation
- 1999-12-16 EP EP99964583A patent/EP1140837B1/en not_active Expired - Lifetime
- 1999-12-16 TR TR2001/01709T patent/TR200101709T2/xx unknown
- 1999-12-16 BR BR9916282-2A patent/BR9916282A/pt not_active IP Right Cessation
- 1999-12-16 CZ CZ20012209A patent/CZ20012209A3/cs unknown
- 1999-12-16 ES ES99964583T patent/ES2226488T3/es not_active Expired - Lifetime
- 1999-12-16 CN CN99814654A patent/CN1330637A/zh active Pending
- 1999-12-16 WO PCT/EP1999/010000 patent/WO2000037444A1/en not_active Application Discontinuation
- 1999-12-16 AT AT99964583T patent/ATE273954T1/de not_active IP Right Cessation
- 1999-12-16 HU HU0104867A patent/HUP0104867A3/hu unknown
- 1999-12-16 CA CA002355630A patent/CA2355630A1/en not_active Abandoned
- 1999-12-16 JP JP2000589516A patent/JP4431282B2/ja not_active Expired - Lifetime
- 1999-12-16 IL IL14290899A patent/IL142908A0/xx unknown
- 1999-12-16 AU AU30391/00A patent/AU760169B2/en not_active Ceased
- 1999-12-16 PE PE1999001274A patent/PE20001387A1/es not_active Application Discontinuation
- 1999-12-16 US US09/868,395 patent/US6867192B1/en not_active Expired - Lifetime
- 1999-12-16 DE DE69919580T patent/DE69919580T2/de not_active Expired - Lifetime
- 1999-12-16 KR KR1020017007579A patent/KR20010101258A/ko not_active Application Discontinuation
- 1999-12-17 GT GT199900217A patent/GT199900217A/es unknown
-
2001
- 2001-05-15 ZA ZA200103948A patent/ZA200103948B/en unknown
- 2001-06-15 NO NO20012995A patent/NO20012995L/no not_active Application Discontinuation
-
2002
- 2002-01-09 HK HK02100145.2A patent/HK1038744A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9916282A (pt) | 2001-10-02 |
| EP1140837A1 (en) | 2001-10-10 |
| KR20010101258A (ko) | 2001-11-14 |
| AU3039100A (en) | 2000-07-12 |
| HK1038744A1 (zh) | 2002-03-28 |
| AU760169B2 (en) | 2003-05-08 |
| ES2226488T3 (es) | 2005-03-16 |
| ATE273954T1 (de) | 2004-09-15 |
| CO5170533A1 (es) | 2002-06-27 |
| JP4431282B2 (ja) | 2010-03-10 |
| HUP0104867A2 (hu) | 2002-04-29 |
| CN1330637A (zh) | 2002-01-09 |
| GB9828074D0 (en) | 1999-02-17 |
| TR200101709T2 (tr) | 2001-12-21 |
| NZ511478A (en) | 2003-08-29 |
| EP1140837B1 (en) | 2004-08-18 |
| WO2000037444A1 (en) | 2000-06-29 |
| DE69919580T2 (de) | 2005-09-01 |
| AR023727A1 (es) | 2002-09-04 |
| NO20012995L (no) | 2001-08-15 |
| HUP0104867A3 (en) | 2002-06-28 |
| US6867192B1 (en) | 2005-03-15 |
| GT199900217A (es) | 2001-06-09 |
| DE69919580D1 (de) | 2004-09-23 |
| PE20001387A1 (es) | 2000-12-22 |
| JP2002533326A (ja) | 2002-10-08 |
| IL142908A0 (en) | 2002-04-21 |
| PL348059A1 (en) | 2002-05-06 |
| CA2355630A1 (en) | 2000-06-29 |
| ZA200103948B (en) | 2002-11-15 |
| CZ20012209A3 (cs) | 2001-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012995D0 (no) | Forbindelse nyttige for behandling av inflammatoriske sykdommer | |
| NO20031443L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| LTC1124961I2 (lt) | Trombopoetino junginiai | |
| ATE229954T1 (de) | Betacarbolinverbindungen | |
| ID28266A (id) | Senyawa-senyawa amidin | |
| DK1028954T3 (da) | Substituerede imidazoler egnede til behandling af inflammatoriske sygdomme | |
| IS5807A (is) | Þíóbensimídasólafleiður | |
| DE69934788D1 (de) | Biozide benzylbiphenylderivative | |
| NO20011745L (no) | Forbindelser | |
| FI4209U1 (fi) | Uusia yhdisteitä | |
| IS5735A (is) | Ný 3-arýl-2-hýdroxýprópínsýruafleiða III | |
| ID26102A (id) | Proses pembuatan senyawa-senyawa stilbena | |
| NO20005006L (no) | Kalsilytiske forbindelser | |
| DK1087992T3 (da) | Antithrombotiske forbindelser | |
| ID17723A (id) | Senyawa untuk pengobatan | |
| NO20006662L (no) | Fluorfenylresin-forbindelser | |
| NO995851L (no) | Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse | |
| NO20012811D0 (no) | Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat | |
| ID26225A (id) | Proses pembuatan senyawa turunan nitroguanidin | |
| SE9801991D0 (sv) | New 3-aryl-2-hydroxypropionic acid derivative II | |
| SE9800626D0 (sv) | Compounds | |
| FI980433A0 (fi) | Foerfarande foer utnyttjande i samband med tillslutandet av en vaetskefoerpackning | |
| SE9804494D0 (sv) | Novel compounds | |
| SE9804493D0 (sv) | Novel compounds | |
| SE9804211D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |